Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease

Respiration

Volumn 82, Issue 6, 2011, Pages 530-538

  Van Durme, Yannick M T A ^a,b   Lahousse, Lies ^a,b   Verhamme, Katia M C ^b   Stolk, Lisette ^b   Eijgelsheim, Mark ^b   Loth, Daan W ^b,c   Uitterlinden, Andre G ^b   Breteler, Monique M B ^b,d   Joos, Guy F ^a   Hofman, Albert ^b,d   Stricker, Bruno H C ^b,c,d   Brusselle, Guy G ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Inspectorate of Healthcare ^*  (Netherlands)

^d NETHERLANDS GENOMICS INITIATIVE   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease, epidemiology, inflammation; Genetics; Interleukin 6

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANALYSIS OF VARIANCE; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 82255162627     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000332336     Document Type: Article

References (45)

1. Pauwels RA, Rabe KF: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620. (Pubitemid 39094180)
2. Rabe KF, Beghe B, Luppi F, Fabbri LM: Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 2007; 175: 1222-1232. (Pubitemid 46905748)
3. van Durme Y, Verhamme KM, Aarnoudse A, Van Pottelberge GR, Hofman A, Witteman JC, Joos GF, Brusselle GG, Stricker BH: Creactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179: 375-382.
4. Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF, Lipinska I, O'Connor GT, Benjamin EJ: Systemic inflammation and COPD - the Framingham Heart Study. Chest 2008; 133: 19-25.
5. Wouters EF: Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 26-33. (Pubitemid 40562960)
6. Dahl M, Vestbo J, Zacho J, Lange P, Tybjaerg- Hansen A, Nordestgaard BG: C reactive protein and chronic obstructive pulmonary disease: A Mendelian randomisation approach. Thorax 2011; 66: 197-204.
7. Piehl-Aulin K, Jones I, Lindvall B, Magnuson A, Abdel-Halim SM: Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease. Respiration 2009; 78: 191-196.
8. Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-1185.
9. Wouters EF, Creutzberg EC, Schols AM: Systemic effects in COPD. Chest 2002; 121: 127S-130S. (Pubitemid 34497329)
10. Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G: Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration 2010; 80: 112-119.
11. Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Mullerova H, Donaldson GC, Wedzicha JA: Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007; 29: 527-534. (Pubitemid 46372101)
12. Pinto-Plata VM, Livnat G, Girish M, Cabral H, Masdin P, Linacre P, Dew R, Kenney L, Celli BR: Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 2007; 131: 37-43. (Pubitemid 46122972)
13. Sabit R, Thomas P, Shale DJ, Collins P, Linnane SJ: The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest 2010; 138: 47-51.
14. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A: Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999; 14: 1015-1022.
15. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J: IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108: 430-438. (Pubitemid 32881066)
16. Ishihara K, Hirano T: IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002; 13: 357-368.
17. Mantovani A, Garlanda C, Doni A, Bottazzi B: Pentraxins in innate immunity: From Creactive protein to the long pentraxin PTX3. J Clin Immunol 2008; 28: 1-13.
18. Naugler W: The wolf in sheep's clothing: The role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 2008; 14: 109-119.
19. Pepys MB, Hirschfield GM: C-reactive protein: A critical update. J Clin Invest 2003; 111: 1805-1812. (Pubitemid 38057722)
20. Vanaudenaerde BM, Verleden SE, Vos R, De Vleeschauwer SI, Willems-Widyastuti A, Geenens R, Van Raemdonck DE, Dupont LJ, Verbeken EK, Meyts I: Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. Am J Respir Crit Care Med 2010; 183: 977-986.
21. Fishman D, Faulds G, Jeffery R, Mohamed- Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin- 6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376. (Pubitemid 28467565)
22. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M, Ratcliffe PJ, Watkins HC, Keavney B: Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002; 53: 1029-1034. (Pubitemid 34261041)
23. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM: Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006; 61: 17-22. (Pubitemid 43106972)
24. Cordoba-Lanus E, de-Torres JP, Lopez- Agui lar C, Rodriguez-Perez MC, Maca- Meyer N, Montejo-de-Garcini A, Aguirre- Jaime A, Perez-Mendez L, Casanova C: Association of IL-6 gene polymorphisms and COPD in a Spanish population. Respir Med 2008; 102: 1805-1811.
25. Seifart C, Dempfle A, Plagens A, Seifart U, Clostermann U, Müller B, Vogelmeier C, von Wichert P: TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 2005; 65: 93-100. (Pubitemid 40179668)
26. He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, Connett JE, Anthonisen NR, Wise RA, Pare PD, Sandford AJ: Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 2009; 64: 698-704.
27. Yanbaeva DG, Dentener MA, Spruit MA, Houwing-Duistermaat JJ, Kotz D, Passos VL, Wouters EF: IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: A case-control study. BMC Med Genet 2009; 10: 23.
28. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA: Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403-422.
29. Hofman A, Breteler MM, van Duijn CM, Janssen HL, Krestin GP, Kuipers EJ, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR, Witteman JC: The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol 2009; 24: 553-572.
30. van Durme Y, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, Joos GF, Stricker BH, Brusselle GG: Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: The Rotterdam Study. Chest 2009; 135: 368-377.
31. van Oijen M, Arp PP, de Jong FJ, Hofman A, Koudstaal PJ, Uitterlinden AG, Breteler MM: Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia - the Rotterdam Study. Neurosci Lett 2006; 402: 113-117.
32. Newton-Cheh C, Eijgelsheim M, Rice KM, de Bakker PI, Yin X, Estrada K, Bis JC, Marciante K, Rivadeneira F, Noseworthy PA, Sotoodehnia N, Smith NL, Rotter JI, Kors JA, Witteman JC, Hofman A, Heckbert SR, O'Donnell CJ, Uitterlinden AG, Psaty BM, Lumley T, Larson MG, Stricker BHC: Common variants at ten loci influence QT interval duration in the QTGEN study. Nat Genet 2009; 41: 399-406.
33. Agusti A: Systemic effects of chronic obstructive pulmonary disease: What we know and what we don't know (but should). Proc Am Thorac Soc 2007; 4: 522-525. (Pubitemid 47547846)
34. Faltraco F, Burger K, Zill P, Teipel SJ, Moller HJ, Hampel H, Bondy B, Ackenheil M: Interleukin- 6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J Am Geriatr Soc 2003; 51: 578-579. (Pubitemid 36457367)
35. Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, Ruidavets JB, Cambien F, Tiret L: Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: The ECTIM study - Etude Cas-Témoin de l'Infarctus du Myocarde. J Mol Med 2001; 79: 300-305. (Pubitemid 32646387)
36. Jahromi MM, Millward BA, Demaine AG: A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 2000; 20: 885-888.
37. Eddahibi S, Chaouat A, Tu L, Chouaid C, Weitzenblum E, Housset B, Maitre B, Adnot S: Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 475-476. (Pubitemid 44285519)
38. Marshall RP, Webb S, Hill MR, Humphries SE, Laurent GJ: Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest 2002; 121: 68S-69S. (Pubitemid 34248347)
39. Pauwels NS, Bracke KR, Maes T, Pilette C, Joos GF, Brusselle GG: The role of interleukin- 6 in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease. Exp Lung Res 2010; 36: 469-483.
40. Smolonska J, Wijmenga C, Postma DS, Boezen HM: Meta-analyses on suspected chronic obstructive pulmonary disease genes: A summary of 20 years' research. Am J Respir Crit Care Med 2009; 180: 618-631.
41. Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, Moukhachen H, Venugopal R, Hasimja D, Kao E, Wallace B, Hersh CP, Bagade S, Bertram L, Silverman EK, Trikalinos TA: The COPD genetic association compendium: A comprehensive online database of COPD genetic associations. Hum Mol Genet 2009; 19: 526-534.
42. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE, Powell JT: Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001; 103: 2260-2265. (Pubitemid 32433715)
43. Margaglione M, Bossone A, Cappucci G, Colaizzo D, Grandone E, Di Minno G: The effect of the interleukin-6 C/G-174 polymorphism and circulating interleukin-6 on fibrinogen plasma levels. Haematologica 2001; 86: 199-204. (Pubitemid 32216095)
44. Chaouat A, Savale L, Chouaid C, Tu L, Sztrymf B, Canuet M, Maitre B, Housset B, Brandt C, Le Corvoisier P, Weitzenblum E, Eddahibi S, Adnot S: Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 2009; 136: 678-687.
45. Okada Y, Takahashi A, Ohmiya H, Kumasaka N, Kamatani Y, Hosono N, Tsunoda T, Matsuda K, Tanaka T, Kubo M, Nakamura Y, Yamamoto K, Kamatani N: Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus. Hum Mol Genet 2011; 20: 1224-1231.